The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Karin, M., Liu, Z.-G., & Zandi, E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80068-3 · Cited by 2,893
The c-fos protein interacts with c-JunAP-1 to stimulate transcription of AP-1 responsive genes
Chiu, R., Boyle, W. J., Meek, J., Smeal, T., Hunter, T., & Karin, M. (1988) · Cell · doi:10.1016/0092-8674(88)90076-1 · Cited by 1,335
Hai, T., & Curran, T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3720 · Cited by 1,294
The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1
Angel, P., Hattori, K., Smeal, T., & Karin, M. (1988) · Cell · doi:10.1016/0092-8674(88)90143-2 · Cited by 1,239 · cited 1×
“The c-jun and atf3 promoters can be activated by cJun :ATF2 and/or ATF2 :ATF2 via Jun :ATF binding sites, whereas the atf3 promoter is inhibited by ATF3 (Angel et al., 1988; Stein et al., 1992; van Dam et al., 1993, 1995; Liang et al., 1996; Wolfgang et al., 2000).”
BackgroundHai, T. W., Liu, F., Coukos, W. J., & Green, M. R. (1989) · Genes & Development · doi:10.1101/gad.3.12b.2083 · Cited by 1,025
Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M., & Karin, M. (1991) · Nature · doi:10.1038/354494a0 · Cited by 789
Bar-Sagi, D., & Hall, A. (2000) · Cell · doi:10.1016/s0092-8674(00)00115-x · Cited by 779
The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun
Jain, J., McCafffrey, P. G., Miner, Z., Kerppola, T. K., Lambert, J. N., Verdine, G. L., Curran, T., & Rao, A. (1993) · Nature · doi:10.1038/365352a0 · Cited by 768
Crystal structure of the heterodimeric bZIP transcription factor c-Fos–c-Jun bound to DNA
Glover, J. N. M., & Harrison, S. C. (1995) · Nature · doi:10.1038/373257a0 · Cited by 735
Cited by
Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks
Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., & Mann, M. (2006) · Cell · doi:10.1016/j.cell.2006.09.026 · Cited by 3,499
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1209 · Cited by 2,242
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194
Chang, F., Steelman, L. S., Lee, J. T., Shelton, J. G., Navolanic, P. M., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402945 · Cited by 725
The Fos family of transcription factors and their role in tumourigenesis
Milde-Langosch, K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.008 · Cited by 583
Gaudray, G., Gachon, F., Basbous, J., Biard-Piechaczyk, M., Devaux, C., & Mesnard, J.-M. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12813-12822.2002 · Cited by 506
Emerging roles of ATF2 and the dynamic AP1 network in cancer
Lopez-Bergami, P., Lau, E., & Ronai, Z. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2681 · Cited by 350
Bradley Shaffer, H., Minx, P., Warren, D. E., Shedlock, A. M., Thomson, R. C., Valenzuela, N., Abramyan, J., Amemiya, C. T., Badenhorst, D., Biggar, K. K., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-3-r28 · Cited by 322
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Mulan: Multiple-sequence local alignment and visualization for studying function and evolution
Ovcharenko, I., Loots, G. G., Giardine, B. M., Hou, M., Ma, J., Hardison, R. C., Stubbs, L., & Miller, W. (2005) · Genome Research · doi:10.1101/gr.3007205 · Cited by 275
Kaji, T., Ishige, A., Hikida, M., Taka, J., Hijikata, A., Kubo, M., Nagashima, T., Takahashi, Y., Kurosaki, T., Okada, M., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120127 · Cited by 263
Cosma, M. P. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00604-4 · Cited by 262
Phosphoenolpyruvate carboxykinase in cell metabolism: Roles and mechanisms beyond gluconeogenesis
Yu, S., Meng, S., Xiang, M., & Ma, H. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101257 · Cited by 261
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
JunB can substitute for Jun in mouse development and cell proliferation
Passegué, E., Jochum, W., Behrens, A., Ricci, R., & Wagner, E. F. (2002) · Nature Genetics · doi:10.1038/ng790 · Cited by 162
Pérez-Cadahía, B., Drobic, B., & Davie, J. R. (2011) · Biochemistry and Cell Biology · doi:10.1139/o10-138 · Cited by 137
Rodríguez-Calvo, R., Tajes, M., & Vázquez-Carrera, M. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1279146 · Cited by 117
“The most common form of AP-1 is the Jun-Fos heterodimer [32].”
BackgroundRole of epithelial nitric oxide in airway viral infection
Xu, W., Zheng, S., Dweik, R. A., & Erzurum, S. C. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.037 · Cited by 85
Type I interferons and endoplasmic reticulum stress in health and disease
(2020) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.10.004 · Cited by 83
“Similar to NF-κB, AP1 is an important inflammatory transcription factor composed of monomers of a variety of proteins, like Jun proto-oncogene or JUN, Fos proto-oncogene or FOS, ATF and/or, musculoaponeurotic fibrosarcoma (MAF) (Uluçkan et al., 2015; van Dam and Castellazzi, 2001; Wagner, 2010) .”
Metadata
- Authors
- van Dam, H., & Castellazzi, M.
- Venue
- Oncogene
- Published
- 2001-04-30
- Volume
- 20
- Issue
- 19
- Pages
- 2453-2464
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2396979416
- Cited by
- 463
- References
- 92
- FWCI
- 9.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.